Ocular Therapeutix Announces Results For Experimental therapy For Treatment of Post-Surgical Ocular Pain And Inflammation
Ocular Therapeutix, Inc. recently announced topline results of their second of two Phase 3 trials evaluating the efficacy and safety of their candidate drug OTX-DP, a compound that releases Sustained Dexamethasone, at a ... Read more